43 results
8-K
EX-99.1
SRZN
Surrozen Inc
1 Apr 24
Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043
8:52am
hepatitis. We look forward to presenting the encouraging Phase 1a data at an upcoming medical conference - the first clinical data for this innovative
424B3
SRZN
Surrozen Inc
8 Nov 23
Prospectus supplement
4:27pm
innovative payment and service delivery models to lower Medicare and Medicaid spending; and
implementation of the federal physician payment transparency
424B3
gr3ws2qqpbt3ioud9r
9 Aug 23
Prospectus supplement
4:39pm
8-K
EX-99.1
gh4qzdb46x9x
9 Aug 23
Surrozen Provides Second Quarter 2023 Financial Results
4:16pm
424B3
wu72ib mwycntu4ajl
10 May 23
Prospectus supplement
4:47pm
8-K
EX-99.1
0t3zdc3483y5zkh
10 May 23
Surrozen Provides First Quarter 2023 Financial Results and Corporate and Pipeline Updates
4:14pm
424B3
zqs am4h8hy5i
7 Apr 23
Prospectus supplement
5:20pm
POS AM
qzcruqykl chp1bxv
31 Mar 23
Prospectus update (post-effective amendment)
9:09am
424B3
eo38df716lo
5 Apr 22
Prospectus supplement
4:43pm
424B3
ggo9 xn472dt5f26d7
30 Mar 22
Prospectus supplement
9:13pm
POS AM
meyp1za29or0582zrhv
28 Mar 22
Prospectus update (post-effective amendment)
9:34pm
424B3
ku2o bendnwjenv34xbj
16 Nov 21
Prospectus supplement
3:04pm